Keith Marchiando - Jun 5, 2024 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Chief Financial Officer
Signature
/s/ Keith Marchiando
Stock symbol
ZIVO
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/6/2024, 06:26 PM
Previous filing
Aug 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Disposed to Issuer -27.1K -100% 0 Jun 5, 2024 Common Stock 27.1K $67.20 Direct F1, F2, F3
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Disposed to Issuer -48K -100% 0 Jun 5, 2024 Common Stock 48K $33.00 Direct F1, F3, F4
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Disposed to Issuer -10.3K -100% 0 Jun 5, 2024 Common Stock 10.3K $23.64 Direct F1, F3, F5
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award +444K 444K Jun 5, 2024 Common Stock 444K $7.96 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 80 reverse stock split of the Issuer's stock in May 2021 and a 1 for 6 reverse stock split of the Issuer's stock in October 2023, as applicable.
F2 The canceled option was fully vested.
F3 The Issuer canceled options for an aggregate 85,416 shares of the Issuer's common stock granted to the Reporting Person on 1/1/2021, 10/21/2021, and 8/29/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 444,498 shares, having an exercise price of $7.96.
F4 The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 10/21/2021 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.
F5 The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 8/29/2022 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.
F6 The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 328,065 immediately upon grant acceptance, 13,551 on July 1, 2024, 13,442 on August 28, 2024, 62,447 on October 21, 2024, 13,551 on January 1, 2025, and 13,442 on August 28, 2025.